127 related articles for article (PubMed ID: 34899841)
1. Identification of an Autophagy-Related Gene Signature for the Prediction of Prognosis in Early-Stage Colorectal Cancer.
Lin XT; Wu QN; Qin S; Fan DJ; Lv MY; Chen X; Cai JW; Weng JR; Zou YF; Rong YM; Gao F
Front Genet; 2021; 12():755789. PubMed ID: 34899841
[No Abstract] [Full Text] [Related]
2. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
3. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.
Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer.
Zhou Z; Mo S; Dai W; Ying Z; Zhang L; Xiang W; Han L; Wang Z; Li Q; Wang R; Cai G
Front Oncol; 2019; 9():878. PubMed ID: 31552190
[No Abstract] [Full Text] [Related]
5. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
[TBL] [Abstract][Full Text] [Related]
6. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer.
Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M
PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544
[TBL] [Abstract][Full Text] [Related]
7. A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients.
Zou YF; Rong YM; Tan YX; Xiao J; Yu ZL; Chen YF; Ke J; Li CH; Chen X; Wu XJ; Lan P; Lin XT; Gao F
Cancer Cell Int; 2019; 19():243. PubMed ID: 31572060
[TBL] [Abstract][Full Text] [Related]
8. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
[TBL] [Abstract][Full Text] [Related]
9. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
Du JX; Chen C; Luo YH; Cai JL; Cai CZ; Xu J; Ni XJ; Zhu W
Gene; 2020 Dec; 762():144974. PubMed ID: 32707305
[TBL] [Abstract][Full Text] [Related]
10. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer.
Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L
J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and predictive value of an autophagy-related signature for early relapse in stages I-III colon cancer.
Mo S; Dai W; Xiang W; Li Y; Feng Y; Zhang L; Li Q; Cai G
Carcinogenesis; 2019 Jul; 40(7):861-870. PubMed ID: 30933267
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
13. ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients.
Shi M; He J
PeerJ; 2016; 4():e1804. PubMed ID: 26989635
[TBL] [Abstract][Full Text] [Related]
14. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of autophagy-related prognostic signature for head and neck squamous cell carcinoma.
Fang J; Yang Z; Xie J; Li Z; Hu C; Yang M; Zhou X
Transl Oncol; 2021 Jul; 14(7):101094. PubMed ID: 33878525
[TBL] [Abstract][Full Text] [Related]
16. Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma.
Kang W; Hu J; Zhao Q; Song F
Front Cell Dev Biol; 2021; 9():731380. PubMed ID: 34746127
[TBL] [Abstract][Full Text] [Related]
17. The Effects of Autophagy-Related Genes and lncRNAs in Therapy and Prognosis of Colorectal Cancer.
Yang Y; Feng M; Bai L; Zhang M; Zhou K; Liao W; Lei W; Zhang N; Huang J; Li Q
Front Oncol; 2021; 11():582040. PubMed ID: 33777735
[TBL] [Abstract][Full Text] [Related]
18. Multi-Size Deep Learning Based Preoperative Computed Tomography Signature for Prognosis Prediction of Colorectal Cancer.
Li CH; Cai D; Zhong ME; Lv MY; Huang ZP; Zhu Q; Hu C; Qi H; Wu X; Gao F
Front Genet; 2022; 13():880093. PubMed ID: 35646105
[No Abstract] [Full Text] [Related]
19. Development and validation of an immune-related gene pairs signature in colorectal cancer.
Wu J; Zhao Y; Zhang J; Wu Q; Wang W
Oncoimmunology; 2019; 8(7):1596715. PubMed ID: 31143520
[TBL] [Abstract][Full Text] [Related]
20. Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients.
Li J; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Deng Y
Cancer Manag Res; 2020; 12():3301-3310. PubMed ID: 32494194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
